During the short period of time that the drug has been on the market, thousands of lawsuits have been filed alleging life-threatening and sometimes fatal side effects.
TheProductLawyers.com reports on the recent influx of lawsuit inquiries that one law firm is receiving after an Alabama woman was awarded $72 million by a jury.
TheProductLawyers.com reports on a recent delay issued by the FDA for a possible antidote to Xarelto, a blood-thinning drug that has allegedly caused a number of adverse side effects for patients.
TheProductLawyers.com reports on litigation issues plaguing Johnson & Johnson dealing with their talcum powder products.
TheProductLawyers.com reports on a recent lawsuit filed by women in Canada related to claims that talcum powder products lead to the development of ovarian cancer.
In Louisiana, another group in excess of 2,800 federal cases have been consolidated by the U.S. Judicial Panel on Multidistrict Litigation (JPML) and given number 2592.
TheProductLawyers.com reports on a recent effort by Johnson & Johnson to have claims of fraud and conspiracy dismissed.
TheProductLawyers.com reports on the recent order given by Judge Eldon Fallon who is overseeing the Xarelto MDL 2592.
The plaintiff alleges that her daughter developed ovarian cancer as a result of using talcum powder for 23 years of her life.
TheProductLawyers.com reports on the controversy swirling about Xarelto, a blood-thinning drug developed by Janssen Pharmaceuticals, a division of Johnson and Johnson, and Bayer AG.
- Home & Family